- Source: inbox/queue/2026-04-28-glp1-managed-access-operating-systems-payer-infrastructure.md - Domain: health - Claims: 2, Entities: 2 - Enrichments: 4 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
1.1 KiB
1.1 KiB
Evernorth EncircleRx
Type: Managed-access program (PBM infrastructure) Parent: Evernorth (Cigna) Domain: GLP-1 utilization management Status: Active
Overview
Evernorth EncircleRx is a managed-access operating system for GLP-1 receptor agonists, managing utilization and cost across 9 million enrolled lives as of 2026.
Program Structure
Cost containment mechanisms:
- 15% cost cap guarantee
- 3:1 savings guarantee (alternative structure)
- $200 copay cap on Wegovy and Zepbound (added 2025)
Operational scale:
- 9 million enrolled lives
- ~$200 million saved since 2024
Strategic Context
EncircleRx represents Evernorth's response to GLP-1 fiscal pressure (10x PMPM increase 2023-2024) by building multi-layer infrastructure beyond traditional formulary management. The program competes with:
- Optum Rx Weight Engage (UHC)
- Manufacturer direct-to-employer channels (Lilly Employer Connect, Novo Nordisk DTE)
Timeline
- 2024 — EncircleRx launched
- 2025 — Added $200 copay cap on Wegovy and Zepbound
- 2026 — Managing 9M lives, ~$200M cumulative savings reported